INTS Intensity Therapeutics
- 3.990
- -0.060-1.48%
Intensity Therapeutics News
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 10-K: Annual report
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wesolowski John M
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Leahy Emer
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GOLDBERG MARK A
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Donovan Daniel
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BENDER LEWIS H
Intensity Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lewis H. Bender(16.1%)
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Talamo Joseph
Intensity Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Talamo Joseph
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | 10-Q: Quarterly report
Intensity Therapeutics | 8-K: Intensity Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
Intensity Therapeutics | 8-K: Current report
Intensity Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Intensity Therapeutics | 10-Q/A: Quarterly report (Amendment)
Intensity Therapeutics | 10-Q: Quarterly report
Analysis
Price Target
No Data
